
Th17 cells could facilitate wider clinical use of adoptive immunotherapy
Medical University of South Carolina (MUSC) investigators report that long-term expansion protocols for adoptive cancer immunotherapy do not compromise Th17 cells' effectiveness against large tumors, in the March 9, 2017 ...
Apr 14, 2017
0
40